Last Updated: May 10, 2026

Drugs Containing Excipient (Inactive Ingredient) GLYCERYL STEARATE


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing GLYCERYL STEARATE excipient, and estimated key patent expiration / generic entry dates

Generic drugs containing GLYCERYL STEARATE excipient

Market Dynamics and Financial Trajectory for Glyceryl Stearate

Last updated: April 8, 2026

Glyceryl stearate is an emulsifier and skin-conditioning agent used in cosmetics, personal care products, and pharmaceuticals. Its market size is driven by growth in skincare, rising demand for natural ingredients, and regulatory shifts favoring safer excipients. The compound’s financial prospects remain robust due to expanding applications and supply chain developments.

Market Overview

Glyceryl stearate’s global market was valued at approximately USD 300 million in 2022. It is expected to reach USD 375 million by 2027, growing at a CAGR of 4.9% during this period (PR Newswire, 2023). The compound accounts for about 10% of the total emulsifier and stabilizer market within cosmetics.

Key Demand Drivers

  • Personal Care Industry: The largest consumer segment, with skincare and haircare products accounting for over 60% of demand (Market Research Future, 2022).
  • Pharmaceutical Formulations: Used as an excipient in topical formulations, with growing use in dermatological drugs.
  • Natural and Organic Products: Increased preference for plant-derived and biodegradable ingredients fuels demand.

Regional Market Distribution

Region Market Share (2022) Growth Rate (2022-2027) Notable Trends
Asia-Pacific 45% 5.5% Rapid growth due to cosmetic manufacturing hub
North America 25% 4.0% Rising organic personal care products
Europe 22% 4.5% Regulatory consolidation favors natural ingredients
Rest of World 8% 4.8% Expanding markets in Latin America and Africa

Supply Chain and Production

Glyceryl stearate is derived from glycerol and stearic acid, both of which are sourced from vegetable oils, primarily soybean, palm, and coconut oils. Major producers include BASF, Croda, and Stearinerie Dubois.

Production involves esterification, with catalysts facilitating the process. Over 80% of supply is concentrated among the top five manufacturers, which face challenges in sourcing raw materials, especially in palm oil, due to sustainability concerns.

Competitive Landscape

Company Market Share Key Products Notable Strategic Moves
BASF 35% Emgrow, and other emulsifiers Investment in sustainable sourcing
Croda International 20% Crodaflex range Expansion into Asia-Pacific markets
Stearinerie Dubois 10% Stearate series R&D in bio-based alternatives
Other players 35% Diversified portfolio Niche focuses on specialty derivatives

Regulatory Environment

Global regulations increasingly favor non-toxic, biodegradable excipients. The EU Cosmetics Regulation (EC) No 1223/2009 classifies glyceryl stearate as a safe ingredient when used within permitted concentrations. The US FDA does not regulate glyceryl stearate as an excipient but emphasizes safety in formulations.

Sustainability policies restrict palm oil sourcing, prompting manufacturers to diversify raw materials or develop bio-based alternatives. Certification standards like RSPO influence sourcing strategies.

Financial Outlook

Revenue growth for glyceryl stearate hinges on the expanding cosmetics and pharmaceutical sectors. Market penetration in organic and natural product lines contributes to premium pricing and profitability. Cost pressures stem from raw material volatility and regulatory compliance.

Profit margins are estimated at 12-15%, with high-volume production and strategic raw material procurement key to maintaining competitiveness. Capital investments focus on sustainable sourcing, process optimization, and R&D for novel derivatives.

Challenges and Risks

  • Raw material shortage, especially sustainable palm oil.
  • Regulatory shifts impacting formulation practices.
  • Competition from bio-based and synthetic alternatives.
  • Price fluctuations in vegetable oils.

Opportunities

  • Developing bio-based and sustainable glyceryl stearate variants.
  • Increasing penetration into emerging markets.
  • Collaborations with regulatory authorities to shape favorable policies.
  • Expansion into new pharmaceutical applications.

Key Takeaways

Glyceryl stearate’s market is underscored by consistent growth in cosmetics and pharmaceuticals, with demand driven by rising consumer awareness of natural ingredients. Supply chain sustainability and regulatory compliance are pivotal. Strategic investments in bio-based processes and geographic expansion underpin future financial performance.

FAQs

Q1: What is the main application of glyceryl stearate?

A: It acts primarily as an emulsifier and skin-conditioning agent in cosmetics and pharmaceuticals.

Q2: Which regions lead the glyceryl stearate market?

A: Asia-Pacific leads, followed by North America and Europe.

Q3: What are key factors influencing prices?

A: Raw material costs, especially vegetable oils, and regulatory compliance.

Q4: Are there alternatives to glyceryl stearate?

A: Yes, compounds like cetearyl alcohol, PEG esters, or bio-based emulsifiers.

Q5: How is sustainability affecting the market?

A: It prompts companies to source sustainable vegetable oils and develop bio-based variants.


References

  1. PR Newswire. (2023). Global glyceryl stearate market report. https://www.prnewswire.com
  2. Market Research Future. (2022). Emulsifiers market analysis. https://www.marketresearchfuture.com

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.